Valeo Pharma's market cap is currently ―. The company's EPS TTM is C$-0.324; its P/E ratio is -0.31; Valeo Pharma is scheduled to report earnings on July 4, 2024, and the estimated EPS forecast is C$-0.05. See an overview of income statement, balance sheet, and cash flow financials.

	Jan 24	Oct 23	Jul 23	Apr 23	Jan 23
Income Statement	-
Total Revenue	C$ 13.54M	C$ 13.11M	C$ 14.08M	C$ 13.56M	C$ 13.16M
Gross Profit	C$ 2.23M	C$ 750.00K	C$ 4.21M	C$ 4.39M	C$ 3.73M
EBIT	C$ -3.06M	C$ -9.08M	C$ -2.38M	C$ -3.14M	C$ -2.99M
EBITDA	C$ -2.41M	C$ -8.32M	C$ -1.75M	C$ -2.51M	C$ -2.37M
Net Income Common Stockholders	C$ -6.87M	C$ -9.24M	C$ -5.84M	C$ -6.48M	C$ -6.25M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	C$ 9.59M	C$ 7.50M	C$ 9.78M	C$ 10.12M	C$ 10.95M
Total Assets	C$ 40.35M	C$ 41.21M	C$ 45.54M	C$ 48.36M	C$ 47.79M
Total Debt	C$ 43.47M	C$ 65.76M	C$ 62.79M	C$ 62.81M	C$ 61.87M
Net Debt	C$ 33.89M	C$ 58.26M	C$ 53.02M	C$ 52.69M	C$ 50.91M
Total Liabilities	C$ 87.37M	C$ 81.54M	C$ 80.58M	C$ 77.53M	C$ 71.36M
Stockholders Equity	C$ -47.01M	C$ -40.34M	C$ -35.05M	C$ -29.16M	C$ -23.57M
Cash Flow	-
Free Cash Flow	C$ 1.86M	-	C$ -1.37M	C$ -911.00K	C$ -11.27M
Operating Cash Flow	C$ 1.63M	C$ -2.67M	C$ -1.26M	C$ -674.00K	C$ -11.09M
Investing Cash Flow	C$ 225.00K	C$ -5.03M	C$ -111.00K	C$ -237.00K	C$ -176.00K
Financing Cash Flow	C$ 460.00K	C$ 5.05M	C$ 1.24M	C$ -57.00K	C$ -50.00K

Currency in CAD

Valeo Pharma Earnings and Revenue History

Income Statement >

Valeo Pharma Debt to Assets

Balance Sheet >

Valeo Pharma Cash Flow

Cash Flow >

Valeo Pharma Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing